Construction of a novel MK-4 biosynthetic pathway in Pichia pastoris through heterologous expression of HsUBIAD1.

Xiaowen Sun, Hui Liu, Peng Wang, Li Wang, Wenfeng Ni, Qiang Yang, Han Wang, Hengfang Tang, Genhai Zhao, Zhiming Zheng
Author Information
  1. Xiaowen Sun: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China.
  2. Hui Liu: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China.
  3. Peng Wang: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China.
  4. Li Wang: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China.
  5. Wenfeng Ni: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China.
  6. Qiang Yang: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China.
  7. Han Wang: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China.
  8. Hengfang Tang: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China.
  9. Genhai Zhao: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China. zhgh327@ipp.ac.cn.
  10. Zhiming Zheng: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, Anhui, People's Republic of China. zhengzhiming2014@163.com. ORCID

Abstract

BACKGROUND: With a variety of physiological and pharmacological functions, menaquinone is an essential prenylated product that can be endogenously converted from phylloquinone (VK) or menadione (VK) via the expression of Homo sapiens UBIAD1 (HsUBIAD1). The methylotrophic yeast, Pichia pastoris, is an attractive expression system that has been successfully applied to the efficient expression of heterologous proteins. However, the menaquinone biosynthetic pathway has not been discovered in P. pastoris.
RESULTS: Firstly, we constructed a novel synthetic pathway in P. pastoris for the production of menaquinone-4 (MK-4) via heterologous expression of HsUBIAD1. Then, the glyceraldehyde-3-phosphate dehydrogenase constitutive promoter (P) appeared to be mostsuitable for the expression of HsUBIAD1 for various reasons. By optimizing the expression conditions of HsUBIAD1, its yield increased by 4.37 times after incubation at pH 7.0 and 24 °C for 36 h, when compared with that under the initial conditions. We found HsUBIAD1 expressed in recombinant GGU-23 has the ability to catalyze the biosynthesis of MK-4 when using VK and VK as the isopentenyl acceptor. In addition, we constructed a ribosomal DNA (rDNA)-mediated multi-copy expression vector for the fusion expression of SaGGPPS and PpIDI, and the recombinant GGU-GrIG afforded higher MK-4 production, so that it was selected as the high-yield strain. Finally, the yield of MK-4 was maximized at 0.24 mg/g DCW by improving the GGPP supply when VK was the isopentenyl acceptor.
CONCLUSIONS: In this study, we constructed a novel synthetic pathway in P. pastoris for the biosynthesis of the high value-added prenylated product MK-4 through heterologous expression of HsUBIAD1 and strengthened accumulation of GGPP. This approach could be further developed and accomplished for the biosynthesis of other prenylated products, which has great significance for theoretical research and industrial application.

Keywords

References

  1. Hum Mutat. 2013 Feb;34(2):317-29 [PMID: 23169578]
  2. PLoS One. 2014 Aug 15;9(8):e104078 [PMID: 25127365]
  3. Metab Eng. 2018 Nov;50:2-15 [PMID: 29704654]
  4. PLoS One. 2013 Aug 19;8(8):e72015 [PMID: 23977195]
  5. Mol Genet Metab Rep. 2014 Sep 19;1:407-411 [PMID: 27896114]
  6. Biotechnol Adv. 2018 Jan - Feb;36(1):182-195 [PMID: 29129652]
  7. Biotechnol Adv. 2017 Nov 1;35(6):681-710 [PMID: 28760369]
  8. Development. 2013 Apr;140(8):1713-9 [PMID: 23533172]
  9. Appl Biochem Biotechnol. 2007 Aug;142(2):105-24 [PMID: 18025573]
  10. Annu Rev Nutr. 2018 Aug 21;38:127-151 [PMID: 29856932]
  11. Mol Cell Biol. 1989 Mar;9(3):1316-23 [PMID: 2657390]
  12. FEMS Yeast Res. 2009 Dec;9(8):1260-70 [PMID: 19799640]
  13. Metab Eng. 2008 May-Jul;10(3-4):201-6 [PMID: 18485776]
  14. Elife. 2015 Mar 05;4:null [PMID: 25742604]
  15. J Mol Biol. 2004 Jul 16;340(4):783-95 [PMID: 15223320]
  16. Biotechnol Bioeng. 1999 Jan 20;62(2):235-41 [PMID: 10099534]
  17. Crit Rev Biotechnol. 2015 Jun;35(2):199-208 [PMID: 24044610]
  18. Biotechnol Prog. 2000 Nov-Dec;16(6):922-6 [PMID: 11101317]
  19. Nat Biotechnol. 2009 Jun;27(6):561-6 [PMID: 19465926]
  20. ACS Synth Biol. 2019 Jul 19;8(7):1620-1630 [PMID: 31250633]
  21. Evid Based Complement Alternat Med. 2013;2013:287358 [PMID: 24062781]
  22. J Lipid Res. 2016 Jul;57(7):1286-99 [PMID: 27121042]
  23. Appl Biochem Biotechnol. 2010 Nov;162(7):2037-48 [PMID: 20455033]
  24. J Ind Microbiol Biotechnol. 2017 Jul;44(7):973-985 [PMID: 28258406]
  25. Nucleic Acids Res. 1987 May 11;15(9):3859-76 [PMID: 3108861]
  26. Curr Opin Biotechnol. 2002 Aug;13(4):329-32 [PMID: 12323354]
  27. Comput Appl Biosci. 1995 Dec;11(6):681-4 [PMID: 8808585]
  28. Biotechnol Rep (Amst). 2015 Mar 26;6:112-118 [PMID: 28626704]
  29. Nature. 2010 Nov 4;468(7320):117-21 [PMID: 20953171]
  30. PLoS One. 2015 Apr 15;10(4):e0125737 [PMID: 25874989]
  31. Yeast. 2005 Mar;22(4):249-70 [PMID: 15704221]
  32. BMC Biotechnol. 2015 Sep 26;15:88 [PMID: 26410558]
  33. Biotechnol Bioeng. 2002 Aug 20;79(4):438-49 [PMID: 12115407]
  34. Microb Cell Fact. 2006 Apr 06;5:17 [PMID: 16600031]
  35. PLoS One. 2018 Apr 4;13(4):e0195432 [PMID: 29617432]
  36. J Biosci Bioeng. 2003;95(3):283-7 [PMID: 16233406]
  37. Gene. 1997 Feb 20;186(1):37-44 [PMID: 9047342]
  38. Methods Enzymol. 2017;584:309-347 [PMID: 28065269]
  39. Int J Oncol. 2003 Sep;23(3):627-32 [PMID: 12888897]
  40. PLoS One. 2016 Aug 29;11(8):e0161886 [PMID: 27570977]
  41. World J Microbiol Biotechnol. 2017 Mar;33(3):52 [PMID: 28197940]
  42. J Biol Chem. 1994 May 20;269(20):14792-7 [PMID: 8182085]
  43. Appl Microbiol Biotechnol. 2014 Jun;98(12):5301-17 [PMID: 24743983]
  44. Nucleic Acids Res. 2007 Jul;35(Web Server issue):W585-7 [PMID: 17517783]
  45. FEMS Microbiol Rev. 2000 Jan;24(1):45-66 [PMID: 10640598]
  46. J Ind Microbiol Biotechnol. 2009 Nov;36(11):1435-8 [PMID: 19760441]
  47. Microb Cell Fact. 2003 Jun 18;2(1):6 [PMID: 12871597]
  48. Appl Microbiol Biotechnol. 2019 Sep;103(18):7519-7535 [PMID: 31378837]
  49. Bioprocess Biosyst Eng. 2009 Oct;32(6):729-35 [PMID: 19153769]
  50. PLoS Biol. 2014 Jul 22;12(7):e1001911 [PMID: 25051182]

Grants

  1. 1608085QC46/Natural Science Foundation of Anhui Province
  2. 1908085MB43/Natural Science Foundation of Anhui Province
  3. 1908085MB48/Natural Science Foundation of Anhui Province
  4. 17030801036/Major Projects of Science and Technology in Anhui Province
  5. 1804b06020342/Key research and development plan of Anhui Province

MeSH Term

Biosynthetic Pathways
Dimethylallyltranstransferase
Gene Expression Regulation, Fungal
Pichia
Recombinant Proteins
Vitamin K 2

Chemicals

Recombinant Proteins
Vitamin K 2
menatetrenone
Dimethylallyltranstransferase
UBIAD1 protein, human

Word Cloud

Created with Highcharts 10.0.0expressionHsUBIAD1pastorisMK-4VKheterologouspathwayPprenylatedPichiaconstructednovelbiosynthesismenaquinoneproductviabiosyntheticsyntheticproductionconditionsyield0recombinantisopentenylacceptorGGPPBACKGROUND:varietyphysiologicalpharmacologicalfunctionsessentialcanendogenouslyconvertedphylloquinonemenadioneHomosapiensUBIAD1methylotrophicyeastattractivesystemsuccessfullyappliedefficientproteinsHoweverdiscoveredRESULTS:Firstlymenaquinone-4glyceraldehyde-3-phosphatedehydrogenaseconstitutivepromoterappearedmostsuitablevariousreasonsoptimizingincreased437timesincubationpH724 °C36 hcomparedinitialfoundexpressedGGU-23abilitycatalyzeusingadditionribosomalDNArDNA-mediatedmulti-copyvectorfusionSaGGPPSPpIDIGGU-GrIGaffordedhigherselectedhigh-yieldstrainFinallymaximized24 mg/gDCWimprovingsupplyCONCLUSIONS:studyhighvalue-addedstrengthenedaccumulationapproachdevelopedaccomplishedproductsgreatsignificancetheoreticalresearchindustrialapplicationConstructionAromaticprenyltransferaseGeranylgeranyldiphosphatesynthaseMenaquinone

Similar Articles

Cited By